Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.

Authors :: Gaber, A.O.
First, M.R.
Tesi, R.J.
Gaston, R.S.
Mendez, R.
Mulloy, L.L.
Light, J.A.
Gaber, L.W.
Squiers, E.
Taylor, R.J.
Neylan, J.F.
Steiner, R.W.
Knechtle, S.
Norman, D.J.
Shihab, F.
Basadonna, G.
Brennan, D.C.
Hodge, E.E.
Kahan, B.D.
Source :: Transplantation; Jul98, Vol. 66 Issue 1, p29, 9p
Publication Year :: 1998

Full Text Access

Tools